Daiwa Securities Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
AC
VPC
OM
EAM
Daiwa Securities Group's VYGR Position: Q1 2026 in Review
Daiwa Securities Group sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 201 shares — an estimated $1K sold.
Daiwa Securities Group first reported a position in VYGR in Q1 2018 and held it in 23 quarters. The position peaked at $6K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.
- Daiwa Securities Group reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 201 Voyager Therapeutics shares in Q1 2026, an estimated $1K.
- Daiwa Securities Group first reported a position in Voyager Therapeutics in Q1 2018 and held it in 23 quarters.
- Daiwa Securities Group's Voyager Therapeutics position peaked at $6K in Q2 2019.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.